HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sophie Gunn Selected Research

TB 402

6/2013Single-dose TB-402 or rivaroxaban for the prevention of venous thromboembolism after total hip replacement. A randomised, controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sophie Gunn Research Topics

Disease

1Hemorrhage
06/2013
1Venous Thromboembolism
06/2013

Drug/Important Bio-Agent (IBA)

1TB 402IBA
06/2013
1RivaroxabanIBA
06/2013
1Monoclonal AntibodiesIBA
06/2013
1Factor VIII (Coagulation Factor VIII)IBA
06/2013

Therapy/Procedure

1Hip Replacement Arthroplasty (Total Hip Replacement)
06/2013
1Knee Replacement Arthroplasty (Total Knee Replacement)
06/2013